Clarithromycin-resistant Helicobacter pylori in Africa: a systematic review and meta-analysis
- PMID: 40221805
- PMCID: PMC11993951
- DOI: 10.1186/s13756-025-01533-6
Clarithromycin-resistant Helicobacter pylori in Africa: a systematic review and meta-analysis
Abstract
Background: In 2022, approximately 56.5% of adults and 47.1% of children and adolescents were affected by Helicobacter pylori (H. pylori) infection in Africa, and clarithromycin-resistant H. pylori (CRHp) strains have become global priority pathogens. Therefore, this study aimed to conduct the first comprehensive systematic review and meta-analysis of CRHp in Africa.
Methods: This investigation was conducted according to the guidelines of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (The PRISMA 2020). Literature search of electronic databases (Google Scholar, African Journals Online, ResearchGate, PubMed, Embase, and Scopus) was performed using keywords "clarithromycin", "Helicobacter pylori", "African country name", "mutation in the 23S rRNA".
Results: Sixty-five studies involving 5,313 H. pylori strains isolated over 26 years (1997-2022) from 23 African countries were included in this study. The samples from which CRHp was isolated included gastric biopsy (60/63; 95%), and stool (4/63; 6%). The pooled prevalence of CRHp in Africa was 27% (95% CI: 22, 33). There was a steady trend in the prevalence of CRHp isolated in Africa over the 26 years (R2 = 0.0001, p = 0.92, slope coefficient of -0.05x). Ten types of 23S rRNA mutations (conferring clarithromycin resistance) were identified, and included mainly A2143G (465 H. pylori strains out of 1178 tested) and A2142G (344 H. pylori strains out of 1027).
Conclusion: To enhance the accuracy and validity of surveillance data for H. pylori in Africa, there is an urgent need for implementing standardized microbiological methods for resistance detection. The prevalence of CRHp reported in this study was very similar to the overall global prevalence and there is a need for more representative studies on CRHp in Africa. While waiting for this, the treatment of H. pylori infections must be based on the guidelines of the AHMSG first Lagos consensus.
Keywords: Helicobacter pylori; Antimicrobial resistance in Africa; Clarithromycin resistance; Global priority pathogens; Meta-analysis; Systematic review.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
CRHP Finder, a webtool for the detection of clarithromycin resistance in Helicobacter pylori from whole-genome sequencing data.Helicobacter. 2020 Dec;25(6):e12752. doi: 10.1111/hel.12752. Epub 2020 Aug 26. Helicobacter. 2020. PMID: 32844531
-
PCR-RFLP detection of point mutations A2143G and A2142G in 23S rRNA gene conferring resistance to clarithromycin in Helicobacter pylori strains.Acta Biochim Pol. 2014;61(2):311-5. Epub 2014 Jun 13. Acta Biochim Pol. 2014. PMID: 24927236
-
Genotyping and antimicrobial resistance patterns of Helicobacter pylori in human and dogs associated with A2142G and A2143G point mutations in clarithromycin resistance.Microb Pathog. 2018 Oct;123:330-338. doi: 10.1016/j.micpath.2018.07.016. Epub 2018 Jul 18. Microb Pathog. 2018. PMID: 30031039
-
Characterization of clarithromycin-resistant Helicobacter pylori strains in Iran: A systematic review and meta-analysis.J Glob Antimicrob Resist. 2017 Sep;10:171-178. doi: 10.1016/j.jgar.2017.05.021. Epub 2017 Jul 18. J Glob Antimicrob Resist. 2017. PMID: 28732793
-
Detection of clarithromycin-resistant Helicobacter pylori by stool PCR in children: a comprehensive review of literature.Helicobacter. 2013 Apr;18(2):89-101. doi: 10.1111/hel.12016. Epub 2012 Oct 12. Helicobacter. 2013. PMID: 23067446 Review.
Cited by
-
Recommendations and Adjuvant Therapies to Mitigate Clarithromycin-Resistant Helicobacter pylori-Associated Infections in Africa.Infect Drug Resist. 2025 Jun 26;18:3169-3174. doi: 10.2147/IDR.S528422. eCollection 2025. Infect Drug Resist. 2025. PMID: 40599638 Free PMC article. Review.
References
-
- Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global prevalence of Helicobacter pylori infection: systematic review and Meta-analysis. Gastroenterology. 2017;153:420–9. - PubMed
-
- Chen Y-C, Malfertheiner P, Yu H-T, Kuo C-L, Chang Y-Y, Meng F-T, et al. Global prevalence of Helicobacter pylori infection and incidence of gastric Cancer between 1980 and 2022. Gastroenterology. 2024;166:605–19. - PubMed
-
- Smith SI, Schulz C, Ugiagbe R, Ndip R, Dieye Y, Leja M, et al. Helicobacter pylori Diagnosis and treatment in Africa: The First Lagos Consensus Statement of the African Helicobacter and Microbiota Study Group. Dig Dis. 2024;42:240–56. - PubMed
-
- Segal I, Ally R, Mitchell H. Helicobacter pylori—an African perspective. QJM: Int J Med. 2001;94:561–5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical